Harbin First Hospital
Harbin First Hospital
Harbin, China3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia | Cancer Treatment-Induced Thrombocytopenia | Recruiting | Phase 2 / Phase 3 | 2026-09-09 | NCT06456528 | |
| Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, thrombocytosis disease | Recruiting | Phase 2 | 2025-11-17 | NCT06552429 | |
| Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer | hepatocellular carcinoma | Not yet recruiting | Not stated | 2025-06-05 | NCT07007286 |